European Journal of Nuclear Medicine

, Volume 23, Issue 5, pp 534–538 | Cite as

Leakage measurement during selective limb perfusion using a gamma probe

  • Dirk Sandrock
  • Friedemann Horst
  • Wolfgang Gatzemeier
  • Martina Ghorbani
  • Helmut Rauschecker
  • Dieter L. Munz
  • Dieter Emrich
Original Article


The objective of this study was to establish a probe system for intraoperative quantitative leakage measurement during selective limb perfusion for adjuvant high-dose chemotherapy in patients with malignant melanomas. We used a portable gamma probe with digital display and investigated the physical properties in a phantom study simulating blood pool activity at different angles of the probe to the surface and different distances. In 20 patients the limb circulation was surgically separated from the systemic blood circulation, and the limb was then selectively perfused (cytostatics added) for 60 min. Initially, 15 MBq technetium-99m labelled autologous red blood cells was injected into the limb circulation, and an equal amount was kept as a standard. Every 10 min, blood samples were drawn from the body circulation and count rates were simultaneously measured by the probe system at the lower end of the sternal body. At the end of perfusion, the circulation of the limb was reconnected, the standard injected into the systemic circulation, and a blood sample drawn after 10 min. All blood samples were counted for calculation of leakage in terms of percent of the injected dose, and the results compared with the intraoperative count rates of the probe system. In the range of leakage observed in this study (0%–86%), the count rate of the probe system (corrected for blood volume, i.e. for body surface) correlated with the results of conventional measurement (r=0.92) according to the equation: %leakage=counts per sx[1.2×body surface (m2)−1.19]. In conclusion, the use of the described probe system is a feasible approach for leakage quantification which continuously yields data during selective limb perfusion.

Key words

Regional chemotherapy Probe system Leakage 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Fletcher JR, White CR, Fletcher WS. Improved survival rates of patients with acral lentiginous melanoma treated with hyperthermie isolation perfusion, wide excision, and regional lymphadenectomy.Am J Surg 1986; 151: 593–598.Google Scholar
  2. 2.
    Krements ET, Carter RD, Sztherland CM, Muchmore JH. Chemotherapy by regional perfusion for limb melanoma.Am Surg 1987; 53: 133–140.Google Scholar
  3. 3.
    Ghussen F, Krueger I, Groth W, Stützer H. The role of regional hyperthermie cytostatic perfusion in the treatment of extremity melanoma.Cancer 1988; 61: 654–659.Google Scholar
  4. 4.
    Kroon BRB. Regional isolation perfusion in melanoma of the limbs; accomplishment, unsolved problems, future.Eur J Surg Oncol 1988; 14: 101–110.Google Scholar
  5. 5.
    Santinami M, Belli F, Cascinelli N, Rovini D, Vaglini M. Seven years' experience with hyperthermie perfusion in extracorporeal circulation for melanoma of the extremities.J Surg Oncol 1989; 42: 201–208.Google Scholar
  6. 6.
    Siddik ZH, Edwards MJ, Boddie AW. Isolated limb perfusion with chemotherapeutic agents for melanoma: a reevaluation of drug dosimetry.Eur J Cancer Clin Oncol 1989; 25: 1393–1397.Google Scholar
  7. 7.
    Coit DG. Hyperthermie isolation limb perfusion for malignant melanoma.Cancer Invest 1992; 10: 277–284.Google Scholar
  8. 8.
    Stehlin JS, Clark RL, White EC, Healy JE, Dewey WC, Beerstecher S. The leakage factor in regional perfusion with chemotherapeutic agents.Arch Surg 1960; 80: 934–945.Google Scholar
  9. 9.
    Hafstroem L, Hugander A, Joensson PE, Westling H, Ehrsson H. Blood leakage and melphalan leakage from the perfusion circuit during regional hyperthermie perfusion for malignant melanoma.Cancer Treat Rep 1984; 68: 867–872.Google Scholar
  10. 10.
    Krige JEJ, King HS, Strover RM. Prophylactic hyperthermie limb perfusion in stage I melanoma.Eur J Surg Oncol 1988; 14: 321–326.Google Scholar
  11. 11.
    Sardi A, Minton JP, Mojzisik C, Nieroda CA, Ferrara PJ, Hinkle GH, Thurston MO, Martin GH. The use of a hand-held gamma detector improves the safety of isolated limb perfusion.J Surg Oncol 1989; 41: 172–176.Google Scholar
  12. 12.
    Manner M, Sinn H, Bubeck H, Kettelhack C, Schlag P. Verbesserte intraoperative Leckkontrolle bei der isolierten Zytostatikaperfusion von Extremitätentumoren.Langenbecks Arch Chir 1990; 375: 208–213.Google Scholar
  13. 13.
    Alexander C, Omlor G, Berberich R, Gross G, Feifel G. Rapid measurement of blood leakage during regional chemotherapy.Eur J Nucl Med 1993; 20: 187–191.Google Scholar
  14. 14.
    Sprenger HJ, Markwardt J, Schlag PM. Quantitative Leckkontrolle mit Radionukliden bei der isolierten Extremitätenperfusion.Nucl Med 1994; 33: 248–253.Google Scholar
  15. 15.
    Hickernell TS, Barber HB, Barrett HH, Woolfenden JM. Dual-detector probe for surgical tumor staging.J Nucl Med 1988; 29: 1101–1106.Google Scholar
  16. 16.
    Adams S, Hovy L, Baum RP, Adams M, Maul FD, Kahla-Witzsch H, Zicher L, Jonas D, Hör G. Preoperative localization of metastases with a hand-held gamma-probe.Nucl Med 1995; 34: 161–164.Google Scholar
  17. 17.
    Kirchner B, Hillmann A, Lottes G, Sciuk J, Bartenstein P, Winkelmann W, Schober O. Intraoperative, probe-guide curettage of osteoid osteoma.Eur J Nucl Med 1993; 20: 609–613.Google Scholar
  18. 18.
    Ricard M, Tenenbaum F, Schlumberger M, Travagli JP, Lumbrosco J, Revillon Y, Parmentier C. Intraoperative detection of pheochromocytoma with iodine-125 labelled meta-iodobenzylguanidine: a feasibility study.Eur J Nucl Med 1993; 20:426–430.Google Scholar
  19. 19.
    Ciba-Geigy. Wissenschaftliche Tabellen Geigy, Teilband Hämatologie und Humangenetik, 8th edn. Basel: Ciba Geigy, 1979.Google Scholar
  20. 20.
    Wieberdink J, Benckhuysen C, Braat RP, Van Slooten EA, Olthuis GAA. Dosimetry in isolation perfusion of the limbs by assessment of perfused tissue volume and grading of toxic tissue reactions.Eur J Cancer Clin Oncol 1982; 18: 905–910.Google Scholar
  21. 21.
    Van Os J, Koops HS, Oldhoff J. Dosimetry of cytostatics in hyperthermic regional isolated perfusion.Cancer 1985; 55: 698–701.Google Scholar
  22. 22.
    Siddik ZH, Edwards MJ, Boddie AW. Isolated limb perfusion with chemotherapeutic agents for melanoma: a reevaluation of drug dosimetry.Eur J Cancer Clin Oncol 1989; 23: 1393–1397.Google Scholar

Copyright information

© Springer-Verlag 1996

Authors and Affiliations

  • Dirk Sandrock
    • 1
    • 3
  • Friedemann Horst
    • 2
  • Wolfgang Gatzemeier
    • 2
  • Martina Ghorbani
    • 1
  • Helmut Rauschecker
    • 2
  • Dieter L. Munz
    • 1
    • 3
  • Dieter Emrich
    • 1
  1. 1.Department of Nuclear MedicineGeorg-August UniversityGöttingenGermany
  2. 2.Department of Oncologic SurgeryGeorg-August UniversityGöttingenGermany
  3. 3.Clinic of Nuclear Medicine, Medical Faculty CharitéHumboldt UniversityBerlinGermany

Personalised recommendations